Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 08/19/2026 | Verkauf | 59.97 | 2,994 | 179,550 | Form 4 |
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 08/19/2026 | Verkauf | 57.94 | 500 | 28,970 | Form 4 |
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 08/19/2026 | Verkauf | 56.47 | 100 | 5,647 | Form 4 |
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 08/19/2026 | Verkauf | 55.97 | 3,094 | 173,171 | Form 4 |
| TEM | Rogers James William | Chief Financial Officer | 08/19/2026 | Verkauf | 60.00 | 26,313 | 1,578,780 | Form 4 |
| TEM | Polovin Andrew | EVP, Chief Legal Officer | 08/19/2026 | Verkauf | 56.00 | 7,927 | 443,912 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 165.08 | 88 | 14,527 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 175.10 | 1,184 | 207,324 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 172.01 | 1,377 | 236,854 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 169.09 | 150 | 25,364 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 165.96 | 194 | 32,197 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 162.05 | 23 | 3,727 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 167.99 | 339 | 56,949 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 167.15 | 568 | 94,941 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 174.02 | 2,044 | 355,700 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 171.31 | 573 | 98,162 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 175.76 | 264 | 46,401 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 173.14 | 2,143 | 371,036 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 08/19/2026 | Verkauf | 170.05 | 107 | 18,195 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 174.02 | 418 | 72,741 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 165.08 | 18 | 2,971 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 171.31 | 117 | 20,044 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 175.10 | 242 | 42,375 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 170.05 | 22 | 3,741 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 167.15 | 116 | 19,389 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 165.96 | 40 | 6,639 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 175.76 | 54 | 9,491 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 173.14 | 438 | 75,835 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 162.05 | 5 | 810 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 172.01 | 281 | 48,334 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 169.09 | 31 | 5,242 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/19/2026 | Verkauf | 167.99 | 69 | 11,591 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 08/19/2026 | Verkauf | 175.00 | 1,125 | 196,875 | Form 4 |
| TENB | Zecher Linda Kay | Director | 08/18/2026 | Verkauf | 35.46 | 700 | 24,822 | Form 4 |
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 08/18/2026 | Verkauf | 49.61 | 9,232 | 458,000 | Form 4 |
| TEM | Rogers James William | Chief Financial Officer | 08/18/2026 | Verkauf | 49.61 | 22,529 | 1,117,664 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 08/18/2026 | Verkauf | 49.61 | 41,095 | 2,038,723 | Form 4 |
| TEM | Polovin Andrew | EVP, Chief Legal Officer | 08/18/2026 | Verkauf | 49.61 | 22,148 | 1,098,762 | Form 4 |
| TEM | Bartolucci Ryan M | Chief Accounting Officer | 08/18/2026 | Verkauf | 49.61 | 6,175 | 306,342 | Form 4 |
| TEM | Lefkofsky Eric P | CEO and Chairman | 08/18/2026 | Verkauf | 49.61 | 132,591 | 6,577,840 | Form 4 |
| TEVA | Lippman Evan | EVP, Business Development | 08/17/2026 | Verkauf | 36.57 | 18,600 | 680,291 | Form 4 |
| TELA | Getz Heather C | Chief Executive Officer | 08/17/2026 | Kauf | 0.6649 | 12,500 | 8,311 | Form 4 |
| TER | Smith Gregory Stephen | President and CEO | 08/17/2026 | Verkauf | 425.00 | 4,000 | 1,700,000 | Form 4 |
| TER | Matz Marilyn | Director | 08/17/2026 | Verkauf | 425.00 | 1,200 | 510,000 | Form 4 |
| TECH | Kelderman Kim | Chief Executive Officer | 08/15/2026 | Steuer-Abgabe | 72.40 | 10,821 | 783,440 | Form 4 |
| TECH | Kelderman Kim | Chief Executive Officer | 08/15/2026 | Optionsausübung | — | 21,470 | — | Form 4 |
| TECH | Hippel James | CFO | 08/15/2026 | Steuer-Abgabe | 72.40 | 4,310 | 312,044 | Form 4 |
| TECH | Hippel James | CFO | 08/15/2026 | Optionsausübung | — | 9,779 | — | Form 4 |
| TECH | Geist William | PRESIDENT, PROTEIN SCIENCES | 08/15/2026 | Steuer-Abgabe | 72.40 | 1,976 | 143,062 | Form 4 |
| TECH | Geist William | PRESIDENT, PROTEIN SCIENCES | 08/15/2026 | Optionsausübung | — | 6,416 | — | Form 4 |
| TECH | Bohnen Shane | SVP - General Counsel | 08/15/2026 | Steuer-Abgabe | 72.40 | 1,343 | 97,233 | Form 4 |
| TECH | Bohnen Shane | SVP - General Counsel | 08/15/2026 | Optionsausübung | — | 4,350 | — | Form 4 |
| TECH | Crouse Steven C. | President - Diag & Spatial Bi | 08/15/2026 | Steuer-Abgabe | 72.40 | 1,947 | 140,963 | Form 4 |
| TECH | Crouse Steven C. | President - Diag & Spatial Bi | 08/15/2026 | Optionsausübung | — | 5,423 | — | Form 4 |
| TECH | Herr Amy E. | Director | 08/15/2026 | Steuer-Abgabe | 72.40 | 213 | 15,421 | Form 4 |
| TECH | Herr Amy E. | Director | 08/15/2026 | Optionsausübung | — | 589 | — | Form 4 |
| TEM | West Nadja | Director | 08/14/2026 | Verkauf | 53.90 | 3,000 | 161,700 | Form 4 |
| TELA | Getz Heather C | Chief Executive Officer | 08/14/2026 | Kauf | 0.6978 | 15,000 | 10,467 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/14/2026 | Verkauf | 163.22 | 1,472 | 240,262 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 08/14/2026 | Verkauf | 162.38 | 4,600 | 746,925 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).